Log In or Create Account
CROI
Conference on Bacteriophages
RWHAP CLINICAL CONFERENCE
Podcasts
Slides
Question of the Week
Guidelines
Contact
Advanced Search
CME Courses
HIV In-Person and Virtual Courses
Current On-Demand Courses
About Courses
CME Webinars
Upcoming Webinars
Current On-Demand Webinars
MATE Act CME
About Webinars
Dialogues
Upcoming IAS–USA Dialogues: Emerging Infections and Health Threats
On-Demand Dialogues
About Dialogues
Topics In Antiviral Medicine
Current Issues for CME
Previous Issues
TAM
Policies and Practices
Permission Request Form
HIV Drug Resistance
HIV Drug Resistance Resources
HIV Drug Resistance Mutations Chart
Recent Webinars
Journal Articles
Fellow Resources
Resources for Fellows and Others New to the HIV Field
On-Demand Webinars for Fellows
IAS-USA Guidelines and Recommendations
On-Demand Webcasts
Research Collaborations
Additional Resources
About
Scientific Leadership Board
IAS-USA Leadership Award Recipients
Core Faculty
Mission
Staff
CME
Funding Information
Careers
Website Policies
Discrimination and Harassment Policy
Governance
Suggestions and Recommendations from San Francisco Locals
Donate
FAQs
Menu
Topics in Antiviral Medicine
™
November/December 2025
Volume 33, Issue 6
Download here
, or select individual articles
Claim CME
Invited Reviews
Prevention and Management of Viral Hepatitis in Primary Care
Emily A. Min, MD, Philip Bolduc, MD
Updates on Testing, Treatment, and Prevention of Sexually Transmitted Infections in the United States, 2025
Caroline Katzman, MD, Natalie Neu, MD, MPH
Top 10 Questions and Answers From the National Clinician Consultation Center: What is Coming Up for Clinicians Across the United States
Parya Saberi, PharmD, MAS, MFA, Carolyn Chu, MD, MSc
CROI
Conference on Bacteriophages
RWHAP CLINICAL CONFERENCE
Podcasts
Slides
Question of the Week
Guidelines
Contact
CME Courses
HIV In-Person and Virtual Courses
Current On-Demand Courses
About Courses
CME Webinars
Upcoming Webinars
Current On-Demand Webinars
MATE Act CME
About Webinars
Dialogues
Upcoming IAS–USA Dialogues: Emerging Infections and Health Threats
On-Demand Dialogues
About Dialogues
Topics In Antiviral Medicine
Current Issues for CME
Previous Issues
TAM
Policies and Practices
Permission Request Form
HIV Drug Resistance
HIV Drug Resistance Resources
HIV Drug Resistance Mutations Chart
Recent Webinars
Journal Articles
Fellow Resources
Resources for Fellows and Others New to the HIV Field
On-Demand Webinars for Fellows
IAS-USA Guidelines and Recommendations
On-Demand Webcasts
Research Collaborations
Additional Resources
About
Scientific Leadership Board
IAS-USA Leadership Award Recipients
Core Faculty
Mission
Staff
CME
Funding Information
Careers
Website Policies
Discrimination and Harassment Policy
Governance
Suggestions and Recommendations from San Francisco Locals
Donate
FAQs
Practice Question of the Week
August 31, 2026: Management Strategies for Co-occurring Mpox and HIV
A 34-year-old man with untreated HIV (CD4+ count, 38 cells/µL) is diagnosed with mpox. Which of the following management strategies is most appropriate?
A. Administer the Jynneos vaccine in a series of 2 doses 28 days apart
B. Initiate tecovirimat 600 mg orally twice daily with a high-fat meal and treat for 14 days
C. Delay antiretroviral therapy (ART) initiation until mpox lesions resolve
D. Initiate ART while treating mpox and monitor closely for severe disease
View the On-Demand Webinar
View Archived Questions
Leave Feedback
Subscribe
CLOSE
